Authors : Shaik Ali Hassan, Shaik Ali Hassan, Sumit Bhateja, Sumit Bhateja, Geetika Arora, Geetika Arora, Francis Prathyusha, Francis Prathyusha
DOI : 10.18231/j.ijcaap.2020.016
Volume : 5
Issue : 2
Year : 2020
Page No : 73-76
COVID-19 is the ailment realized by an illness of the SARS-CoV-2 contamination, first perceived in the city ofWuhan, in China’s Hubei region in December 2019. COVID-19 was as of late known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) articulated the official name as COVID-19 in February 2020. Many drugs are being tried for coronavirus, but the favipiravir which was accepted for Chinese flu. The dynamic favipiravir restrains RNA polymerase and forestalls replication of the viral genome, this is main work done by the favipiravir. In this review we will learn about how favipiravir can be used and its mechanism its mechanism of action and various trials that support that favipiravir can be medication for treatment of coronavirus.
Keywords: Favipiravir, World health organization, Coronavirus, Chinese flu.